DepoMed urged to consider Horizon Pharma offer

Institutional Shareholder Services recommended that DepoMed Inc. (Nasdaq: DEPO) hold a special shareholder meeting to consider Horizon Pharma's (Nasdaq: HZNP) acquisition offer. Shares of DepoMed leaped $3.35 to close at $18.85 while Horizon Pharma stock surged $3.01 to close at $19.82.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.